Bexarotene

Bexarotene (Targretin) is an oral antineoplastic agent indicated by the FDA for Cutaneous T cell lymphoma. It has been used off-label for lung cancer, breast cancer, and Kaposi's sarcoma.

Bexarotene is a retinoid specifically selective for retinoid X receptors, as opposed to the retinoic acid receptors.